Prestige Consumer Healthcare Inc. Reports Fiscal 2020 Second Quarter and Year-to-Date Results
Revenue $238.1 Million in Q2 Fiscal 2020; Organic Revenue Flat
GAAP Diluted EPS of $0.65 in Q2 Fiscal 2020; Adjusted EPS of $0.68, Up 5% Versus Prior Year Q2
Cash Flow From Operations of $50.2 Million; Non-GAAP Free Cash Flow of $47.2 Million in Q2
Reduced Debt by $46 Million and Completed $50 Million Share Repurchase Program in First Half Fiscal 2020
Reaffirming Previously Issued Organic FY’20 Outlook
TARRYTOWN, N.Y.--(GLOBE NEWSWIRE)-October 31, 2019-- Prestige Consumer Healthcare Inc. (NYSE:PBH) today reported financial results for its second quarter and year-to-date fiscal 2020 ended September 30, 2019.
“Our second quarter and year-to-date results were in-line with our expectations, led by positive consumption trends across our portfolio. Our solid financial profile and cash generation allowed us to opportunistically repurchase shares and further reduce debt during Q2. Based on these solid trends and strong cash flow we are well positioned to achieve our full-year fiscal 2020 guidance,” said Ron Lombardi, Chief Executive Officer of Prestige Consumer Healthcare.
Second Fiscal Quarter Ended September 30, 2019
Reported revenues in the second quarter of fiscal 2020 were $238.1 million compared to $239.4 million in the second quarter of fiscal 2019. Revenues were flat on an organic basis, which excludes the effect of foreign currency. The revenue performance for the quarter was driven by a strong international segment and consumption gains in the Company’s core brand portfolio domestically, offset by continued retailer inventory reductions.
Reported gross profit margin in the second quarter fiscal 2020 was 57.4%, flat with the prior year comparable period. Excluding transition costs associated with a new logistics provider and location, adjusted gross profit margin was 58.0% in second quarter fiscal 2020, an increase versus prior year driven primarily by product mix.
The following information was filed by Prestige Brands Holdings, Inc. (PBH) on Thursday, October 31, 2019 as an 8K 2.02 statement, which is an earnings press release pertaining to results of operations and financial condition. It may be helpful to assess the quality of management by comparing the information in the press release to the information in the accompanying 10-Q Quarterly Report statement of earnings and operation as management may choose to highlight particular information in the press release.
View differences made from one quarter to another to evaluate Prestige Brands Holdings, Inc.'s financial trajectory
Compare this 10-Q Quarterly Report to its predecessor by reading our highlights to see what text and tables were removed, and by Prestige Brands Holdings, Inc..
Ticker: PBH CIK: 1295947 Form Type:10-Q Quarterly Report Accession Number: 0001295947-19-000029 Submitted to the SEC: Thu Oct 31 2019 2:19:20 AM EST Accepted by the SEC: Thu Oct 31 2019 Period: Monday, September 30, 2019 Industry: Pharmaceutical Preparations